Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$406M |
| 2 |
Warner Bros
WBD
|
+$318M |
| 3 |
Chevron
CVX
|
+$238M |
| 4 |
Tesla
TSLA
|
+$165M |
| 5 |
M&T Bank
MTB
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional National Municipal Bond ETF
DFNM
|
+$654M |
| 2 |
Amazon
AMZN
|
+$413M |
| 3 |
AT&T
T
|
+$354M |
| 4 |
Dimensional US High Profitability ETF
DUHP
|
+$263M |
| 5 |
CERN
Cerner Corp
CERN
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.93% |
| 2 | Technology | 15.13% |
| 3 | Industrials | 12.18% |
| 4 | Healthcare | 11.63% |
| 5 | Consumer Discretionary | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Harvard Bioscience
HBIO
$29.2M
| $6.76M | ﹤0.01% |
187,784
-21
| -0% | -$948 |
|
2352
Protagonist Therapeutics
PTGX
$9.44B
| $6.75M | ﹤0.01% |
852,775
-10,117
| -1% | -$122K |
|
2353
MVB Financial
MVBF
$389M
| $6.74M | ﹤0.01% |
216,644
+34,148
| +19% | +$1.29M |
|
|
FINV
2354
FinVolution Group
FINV
$1.15B
| $6.73M | ﹤0.01% |
1,417,488
+259,083
| +22% | +$1.04M |
|
|
PFSW
2355
DELISTED
PFSweb, Inc.
PFSW
| $6.72M | ﹤0.01% |
571,151
+45,779
| +9% | +$550K |
|
2356
Information Services Group
III
$251M
| $6.71M | ﹤0.01% |
993,038
+54,791
| +6% | +$345K |
|
2357
Bausch Health
BHC
$2.34B
| $6.7M | ﹤0.01% |
801,821
+116,872
| +17% | +$1.63M |
|
2358
Willdan Group
WLDN
$1.3B
| $6.7M | ﹤0.01% |
242,917
+23,299
| +11% | +$637K |
|
2359
Ascent Industries
ACNT
$141M
| $6.69M | ﹤0.01% |
475,745
+12,154
| +3% | +$193K |
|
2360
Arcutis Biotherapeutics
ARQT
$3.18B
| $6.66M | ﹤0.01% |
312,608
+85,225
| +37% | +$1.75M |
|
|
TBCH
2361
Turtle Beach Corp
TBCH
$277M
| $6.65M | ﹤0.01% |
543,659
+144,223
| +36% | +$2.45M |
|
|
IVAC
2362
DELISTED
Intevac Inc
IVAC
| $6.63M | ﹤0.01% |
1,369,838
+39,727
| +3% | +$202K |
|
2363
Fate Therapeutics
FATE
$326M
| $6.62M | ﹤0.01% |
267,166
-121,950
| -31% | -$3.36M |
|
2364
Nature's Sunshine
NATR
$288M
| $6.62M | ﹤0.01% |
619,976
+59,382
| +11% | +$825K |
|
2365
OR Royalties Inc
OR
$6.2B
| $6.6M | ﹤0.01% |
653,097
+319,104
| +96% | +$3.83M |
|
2366
First Northwest Bancorp
FNWB
$104M
| $6.6M | ﹤0.01% |
422,801
+7,399
| +2% | +$137K |
|
2367
Mitek Systems
MITK
$834M
| $6.59M | ﹤0.01% |
713,831
-44,074
| -6% | -$469K |
|
2368
Relay Therapeutics
RLAY
$4.33B
| $6.59M | ﹤0.01% |
393,791
+335,925
| +581% | +$7.2M |
|
2369
AstroNova
ALOT
$227M
| $6.58M | ﹤0.01% |
549,451
+5,524
| +1% | +$71.4K |
|
|
PWOD
2370
DELISTED
Penns Woods Bancorp
PWOD
| $6.58M | ﹤0.01% |
284,780
+3,947
| +1% | +$92K |
|
2371
KT
KT
$8.81B
| $6.55M | ﹤0.01% |
469,553
+7,130
| +2% | +$102K |
|
2372
Escalade
ESCA
$311M
| $6.49M | ﹤0.01% |
499,659
+21,550
| +5% | +$282K |
|
2373
LCNB Corp
LCNB
$283M
| $6.48M | ﹤0.01% |
433,292
+30,553
| +8% | +$495K |
|
2374
Parke Bancorp
PKBK
$405M
| $6.47M | ﹤0.01% |
308,889
+24,511
| +9% | +$575K |
|
|
RAD
2375
DELISTED
Rite Aid Corporation
RAD
| $6.46M | ﹤0.01% |
958,866
-791,278
| -45% | -$5.24M |
|
Similar funds
Dimensional Fund Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Dimensional Fund Advisors held 3,609 positions worth $279B, down 14% from $325B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dimensional Fund Advisors's Q2 2022 filing shows 98 new, 1,934 increased, 1,303 reduced and 146 closed positions. Its largest new stake was ESAB: 2,060,747 shares worth $90.2M. The largest sale was Dimensional National Municipal Bond ETF, an estimated $654M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q2 2022 buy was ESAB: 2,060,747 shares worth $90.2M.
- Dimensional Fund Advisors added most to ExxonMobil in Q2 2022, an estimated $406M increase.
- Dimensional Fund Advisors's biggest Q2 2022 reduction was Amazon, cutting an estimated $413M.
- Dimensional Fund Advisors fully exited Dimensional National Municipal Bond ETF in Q2 2022, selling an estimated $654M.
- Dimensional Fund Advisors's ten largest holdings make up 10% of its $279B portfolio in Q2 2022.
- Dimensional Fund Advisors opened 98 new positions and closed 146 in Q2 2022.
- Dimensional Fund Advisors's portfolio value fell 14% quarter-over-quarter to $279B.
Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.